News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,645 Results
Type
Article (27219)
Company Profile (61)
Press Release (367365)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (108048)
Career Advice (619)
Deals (17468)
Drug Delivery (52)
Drug Development (49167)
Employer Resources (57)
FDA (12553)
Job Trends (8728)
News (192315)
Policy (20021)
Tag
Academia (1833)
Accelerated approval (3)
Adcomms (8)
Allergies (73)
Alliances (27937)
ALS (58)
Alzheimer's disease (836)
Antibody-drug conjugate (ADC) (53)
Approvals (12612)
Artificial intelligence (176)
Autoimmune disease (10)
Automation (5)
Bankruptcy (146)
Best Places to Work (7116)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (41)
Bladder cancer (59)
Brain cancer (18)
Breast cancer (194)
Cancer (1454)
Cardiovascular disease (125)
Career advice (542)
Career pathing (15)
CAR-T (72)
Cell therapy (206)
Cervical cancer (13)
Clinical research (41685)
Collaboration (449)
Compensation (126)
Complete response letters (10)
COVID-19 (1592)
CRISPR (12)
C-suite (139)
Cystic fibrosis (44)
Data (1550)
Decentralized trials (2)
Denatured (17)
Depression (30)
Diabetes (177)
Diagnostics (3663)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (54)
Drug pricing (55)
Drug shortages (22)
Duchenne muscular dystrophy (56)
Earnings (37831)
Editorial (23)
Employer branding (8)
Employer resources (51)
Events (52865)
Executive appointments (458)
FDA (13554)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (415)
Gene editing (37)
Generative AI (10)
Gene therapy (133)
GLP-1 (416)
Government (3127)
Grass and pollen (3)
Guidances (42)
Healthcare (12539)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (45)
Indications (20)
Infectious disease (1669)
Inflammatory bowel disease (80)
Inflation Reduction Act (5)
Influenza (29)
Intellectual property (52)
Interviews (82)
IPO (7222)
IRA (21)
Job creations (1905)
Job search strategy (492)
Kidney cancer (7)
Labor market (11)
Layoffs (184)
Leadership (6)
Legal (3766)
Liver cancer (58)
Lung cancer (236)
Lymphoma (102)
Machine learning (3)
Management (22)
Manufacturing (111)
MASH (48)
Medical device (13008)
Medtech (13012)
Mergers & acquisitions (10543)
Metabolic disorders (436)
Multiple sclerosis (54)
NASH (11)
Neurodegenerative disease (51)
Neuropsychiatric disorders (9)
Neuroscience (1175)
NextGen: Class of 2025 (4108)
Non-profit (2952)
Now hiring (16)
Obesity (219)
Opinion (85)
Ovarian cancer (53)
Pain (69)
Pancreatic cancer (54)
Parkinson's disease (90)
Partnered (12)
Patents (115)
Patient recruitment (85)
Peanut (37)
People (36064)
Pharmaceutical (17)
Pharmacy benefit managers (11)
Phase I (11959)
Phase II (18076)
Phase III (14789)
Pipeline (708)
Policy (65)
Postmarket research (1712)
Preclinical (3813)
Press Release (22)
Prostate cancer (78)
Psychedelics (17)
Radiopharmaceuticals (161)
Rare diseases (194)
Real estate (2955)
Recruiting (20)
Regulatory (14624)
Reports (16)
Research institute (1666)
Resumes & cover letters (76)
Rett syndrome (2)
RNA editing (3)
RSV (22)
Schizophrenia (53)
Series A (69)
Series B (49)
Service/supplier (4)
Sickle cell disease (24)
Special edition (3)
Spinal muscular atrophy (106)
Sponsored (13)
Startups (2216)
Stomach cancer (8)
Supply chain (39)
Tariffs (15)
The Weekly (9)
Vaccines (375)
Venture capitalists (17)
Weight loss (142)
Women's health (17)
Worklife (4)
Date
Today (66)
Last 7 days (483)
Last 30 days (1445)
Last 365 days (18879)
2025 (6046)
2024 (20307)
2023 (23355)
2022 (31474)
2021 (33983)
2020 (33326)
2019 (29531)
2018 (22627)
2017 (19676)
2016 (18852)
2015 (21991)
2014 (16604)
2013 (13710)
2012 (14883)
2011 (15125)
2010 (13612)
Location
Africa (397)
Alabama (18)
Alaska (4)
Arizona (120)
Arkansas (10)
Asia (25252)
Australia (4109)
California (3109)
Canada (1247)
China (373)
Colorado (166)
Connecticut (186)
Delaware (115)
Europe (50027)
Florida (554)
Georgia (128)
Idaho (33)
Illinois (362)
India (14)
Indiana (228)
Iowa (4)
Japan (123)
Kansas (73)
Kentucky (12)
Louisiana (7)
Maine (28)
Maryland (637)
Massachusetts (2173)
Michigan (109)
Minnesota (270)
Mississippi (2)
Missouri (53)
Montana (18)
Nebraska (19)
Nevada (34)
New Hampshire (60)
New Jersey (1145)
New Mexico (9)
New York (966)
North Carolina (610)
North Dakota (4)
Northern California (1356)
Ohio (138)
Oklahoma (5)
Oregon (23)
Pennsylvania (836)
Puerto Rico (7)
Rhode Island (24)
South America (561)
South Carolina (21)
Southern California (1193)
Tennessee (78)
Texas (549)
United States (13054)
Utah (113)
Virginia (84)
Washington D.C. (40)
Washington State (242)
West Virginia (3)
Wisconsin (42)
394,645 Results for "extremity medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Extremity Medical to Expand Orthopedic Extremity Implant Systems Through Strategic Relationship With Henry Schein as Well as Growth Financings
In a landmark development for the orthopedic implant industry, Extremity Medical LLC, a pioneering medical engineering firm, has announced a strategic relationship with Henry Schein, Inc., a global healthcare solutions company.
January 11, 2024
·
2 min read
Press Releases
Kuros Biosciences Expands into Extremities Markets
November 19, 2024
·
5 min read
Press Releases
Humacyte Announces Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
February 26, 2025
·
10 min read
Press Releases
FDA Approves First Acellular Tissue Engineered Vessel to Treat Vascular Trauma in Extremities
December 23, 2024
·
4 min read
Press Releases
Humacyte Provides Update on Commercial Launch and Pricing of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma
January 14, 2025
·
11 min read
Press Releases
Humacyte Announces FDA Approval of SYMVESS™ (acellular tissue engineered vessel-tyod) for the Treatment of Extremity Vascular Trauma
December 19, 2024
·
13 min read
Press Releases
Humacyte to Host In-Person and Virtual Investor Event in New York to Discuss Commercial Launch of Symvess™ (acellular tissue engineered vessel-tyod) for Extremity Vascular Trauma on March 6, 2025
March 3, 2025
·
7 min read
Pharm Country
Henry Schein Enters Extremity Segment of Orthopedic Market
Henry Schein, Inc. announced plans to enter the upper- and lower-extremities specialty segment of the orthopedic market in line with our long-standing strategy.
December 20, 2023
·
9 min read
Pharm Country
Extremity Medical Expands into Trauma Market
Extremity Medical announced the release of the OMNI™ Stable Ankle Fracture System.
May 24, 2022
·
2 min read
Press Releases
Tenon Medical(R) Receives Approval for Notice of Allowance from the European Patent Office
March 11, 2025
·
2 min read
1 of 39,465
Next
